Showing posts with label vertical transmission. Show all posts
Showing posts with label vertical transmission. Show all posts

Monday, January 23, 2017

Everything you need to know about Herpes type 1 and type 2.

courtesy: rschealth.com

Herpes simplex virus is still a mystery for researchers and physician because they have yet to explore many things about it. The word ‘Herpes’ have its origin in Greek language and means ‘to crawl or to creep’, a name perfectly suited because once the cells are infected, the virus ascends the nerve pathways to reach dorsal root ganglia and lie dormant there, only to resurface and cause infection sporadically.

Besides Herpes Simplex that causes sexually transmitted diseases, other common Herpes strains include chicken pox or shingles (caused by herpes zoster virus) and Kaposi’s sarcoma (caused by herpes virus 8). 

Herpes simplex primarily infect mouth and genitals and spread by bodily fluids. Two type of Herpes Simplex Viruses are commonly seen in clinical practice: herpes type 1 (HSV1) and herpes type 2 (HSV2).

Herpes Virus type 1


HSV1 is highly contagious  infection. It is endemic  throughout the globe but the age of primary infection varies according to geography. In African subcontinent majority of infection is acquired in childhood  while in America, Europe and western Pacific seroconversion continues well into adulthood.It is  mainly transmitted by oral-to-oral contact to cause oral herpes infection via infected sores, body fluids or surfaces. The oral lesion is  commonly known as cold sores, however it can cause genital herpes due to oral-genital contact too.

A person who has a history of HSV 1 oral herpes infection is unlikely to get HSV1 genital infection in future, but he /she is still at risk of getting HSV2 genital infection.

If a person with Genital Herpes tests positive for HSV1, then there is less chance of infecting the partner The frequency of sporadic shedding and recurrence is much less too in  HSV type 1 infection.

HSV1 is vertically transmitted from mother to fetus if the women acquire genital infection for the first time in late pregnancy. Risk of transmission is very less if she was already infected before pregnancy. She should inform her obstetrician if she gets infected late in pregnancy.

In HIV, infected population HSV1 is known to cause more serious infections and frequent recurrences due to Immunocompromised state. Sometimes, it can cause keratitis and encephalitis.

Herpes Virus type 2


HSV2 is also a  global issue, it is exclusively transmitted sexually, causing genital ulcers or blisters. Its prevalence is highest in African subcontinent where nearly 32% population is harboring the virus. More women are infected with HSV2 than men because men to women transmission is more efficient than women to men.


Herpes simplex virus digital image 


After the first infection and seroconversion, recurrent infections are mild and infrequent, decreasing over time.

It is primarily transmitted through sexual contact with sores, ulcers or bodily fluid of an infected person. Rarely, vertical transmission has also been documented.

People infected with HSV2 are at 3 times higher risk for getting HIV infection. About 60-90% of HIV infected people are also test positive for HSV2.

Contrary to the popular belief that Herpes 1 only infect above the waist and Herpes 2 infect below the belt, Herpes 1 is perfectly capable of causing genital infection and more than half of new genital herpes cases are caused by type1. Similarly, Herpes type 2 can cause cold sores.

According to a 2012 fact sheet by WHO, globally 3709 million (67%) people aged 0-49 have Herpes type 1[1] while 417 million (11.3%) people aged 15–49 years have Herpes type 2.[2] Almost 1 in 6 people in US, aged 15-49 years have Herpes type 2 infection and most people are unaware of it because the symptoms are very mild.

Herpes is a lifelong infection with mild or no symptoms at all making it difficult to estimate the burden of disease. The virus remains dormant in the dorsal root ganglia for unknown period of time and becomes active again and resume shedding. About one-third to half of people who shed virus have no symptoms at all and are being responsible for 70% of transmission.

Both Herpes 1 and 2 can cause cold sores and genital infection but majority of cases of cold sores are caused by Herpes1 and majority of genital infections by Herpes2. This is very important from the point of recurrence, because if Herpes 2 causes you cold sores, it is far less likely to recur and shed the virus sporadically and same holds true for Herpes 1 causing genital infection. They do best when they are in their natural habitat.

The initial orolabial and genital blisters are very severe and subsequent attacks are often very mild and may not cause any symptoms also.

Treatment consists of antivirals like acyclovir, famciclovir, and valaciclovir. They only reduce the severity of symptoms but do not cure the infection.

‘Prevention is the best cure’ paradigm holds good for Herpes Simplex infection. Using barrier methods for protection along with abstaining from sex during symptoms of genital herpes reduces the risk of transmission. Vertical transmission can be prevented by sharing information with the obstetrician. Males undergoing circumcision are at 50% less risk of infection with HSV2, HIV and HPV.[3]

Research is underway to develop vaccines or topical microbicides to prevent the spread of Herpes.   

Herpes and Pregnancy:


According to ACOG

Women who have genital herpes infection late in pregnancy and have a vaginal birth have 30-50% chances of infecting the fetus.

First episode occurring late in pregnancy also have high chances of vertical transmission as opposed to recurrent infection (2-5% chances).

Neonatal infection with Herpes simplex occur in 1in 3500-10,000 livebirths in USA, mostly to those women with asymptomatic or unrecognized infection.

Maternal infections are classified into:

  1. Genital infection is labelled as ‘primary’ when the patient is seronegative for both HSV-1 and HSV-2.
  2. It is labelled as ‘nonprimary first’ when it occurs in patient with prior history of heterologous infection (HSV2 in patient who had prior HSV1 infection and vice versa).
  3. Recurrent when it occurs with clinical or serological evidence of prior genital herpes.  


Misconceptions are rife among physician, researchers, laboratory personnel and patients about ordering and interpreting lab reports for Herpes.  That is the  topic for next article on the blog.



[1] http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0140765
[2] http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0114989

Tuesday, January 19, 2016

Society for Maternal-Fetal Medicine (SMFM) recommendations for screening, treatment, and prevention of vertical transmission of Hepatitis B in pregnancy



The Primary source of this article is the recommendation published by Society for Maternal-Fetal Medicine (SMFM) for screening, treatment and prevention of vertical transmission of Hepatitis B in the January issue of American Journal of Obstetrics and Gynecology by Dionne-Odom J. et al.




Nearly 240 million people worldwide are infected with hepatitis B virus (HBV).

Specific to pregnancy, an estimated prevalence of 0.7-0.9% for chronic hepatitis B infection among pregnant women in the United States has been reported, with >25,000 infants at risk for chronic infection born annually to these women.

While transmission through sexual intercourse and intravenous drug abuse are the major risk factors for acquisition of hepatitis B among adults in the United States, perinatal transmission is responsible for up to 50% of HBV infection worldwide

Vertical transmission of HBV from infected mothers to their fetuses or newborns, either in utero or peripartum, remains a major source of perpetuating the reservoir of chronically infected individuals globally.

From a global public health perspective, chronic HBV infection is the major source of hepatocellular carcinoma, leading to 50% of cases worldwide and 80% in high-endemic areas for HBV.

In contrast to HBV acquisition in adulthood, which more commonly leads to acute resolved infection and immunity, perinatal/neonatal HBV is more likely to lead to chronic infection and its long-term disease risks. Chronic hepatitis B infection will develop in up to 90% of exposed neonates who do not receive appropriate immunoprophylaxis, in contrast to 10-25% of infected children and only 5-10% of exposed immunocompetent adults.

Identification of pregnant women with chronic HBV infection through universal screening has had a major impact in decreasing the risk of neonatal infection. Recent data demonstrate that 95% of pregnant women are currently screened prior to delivery for evidence of chronic HBV infection, with rates of perinatal transmission decreasing significantly over the past 2 decades.

The recommendation of Society for Maternal-Fetal Medicine (SMFM) for screening, treatment and prevention of vertical transmission are:

(1) Perform routine screening during pregnancy for HBV infection with maternal HBsAg testing (grade 1A).

(2) Administer hepatitis B vaccine and HBV immunoglobulin within 12 hours of birth to all newborns of HBsAg-positive mothers or those with unknown or undocumented HBsAg status, regardless of whether maternal antiviral therapy has been given during the pregnancy (grade 1A).

(3) In pregnant women with HBV infection, suggest HBV viral load testing in the third trimester (grade 2B).

(4) In pregnant women with HBV infection and viral load >6-8 log 10 copies/mL, HBV-targeted maternal antiviral therapy should be considered for the purpose of decreasing the risk of intrauterine fetal infection (grade 2B).

(5) In pregnant women with HBV infection who are candidates for maternal antiviral therapy, tenofovir should be used as a first-line agent (grade 2B).

 (6) It is  recommend that women with HBV infection be encouraged to breast-feed as long as the infant receives immunoprophylaxis at birth (HBV vaccination and hepatitis B immunoglobulin) (grade 1C).

 (7) HBV infected women who have an indication for genetic testing, invasive testing (eg amniocentesis or chorionic villus sampling) may be offered–counseling should include the fact that the risk for maternal-fetal transmission may increase with HBV viral load >7 log 10 IU/mL (grade 2C).

(8) Cesarean delivery should not be performed for the sole indication for reduction of vertical HBV transmission (grade 2C).

Issues to be considered in a pregnant woman diagnosed as a chronic HBV carrier?

The majority of pregnant women diagnosed with chronic HBV infection will be asymptomatic and identified through routine screening with initial prenatal laboratory tests.

Identification of a pregnant woman as chronically HBV infected also presents an important opportunity to counsel her regarding risks to other family and household members. HBV is most easily transmitted via sexual exposure or blood exposure but can also be transmitted through casual shared use of household items such as eating utensils and toothbrushes, as well as through personal contact such as kissing or routine childcare. Therefore, family and household members should be evaluated for HBV status and referred for vaccination if found to be uninfected and nonimmune.

The pregnant woman herself should also be assessed for immunity status for hepatitis A and offered vaccination if not immune, since coinfection with another viral hepatitis results in compounded morbidity.

To aid in counseling regarding risks and potential management options as outlined above, baseline LFTs should also be drawn when a positive HBsAg test result is obtained, along with a baseline quantitative HBV-DNA level.

The woman should also be counseled regarding exposures to potentially hepatotoxic medications, even those available over the counter, such as acetaminophen, and to avoid the use of alcohol even when not pregnant.

Even if the maternal viral load is low and antiviral therapy during pregnancy is not recommended, the newborn should still receive standard prophylaxis with HBIG and HBV vaccine within 12 hours of birth, and ongoing surveillance of the woman’s hepatic function after pregnancy is indicated.


References:

Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission.Dionne-Odom, Jodie et al. American Journal of Obstetrics & Gynecology, Volume 214, Issue 1, 6 - 14